TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88377603

Filing Date: 04/09/2019

To the Commissioner for Trademarks:

MARK: ASSEMBLYBIO (stylized and/or with design, see mark)

The literal element of the mark consists of ASSEMBLYBIO.
The applicant is not claiming color as a feature of the mark. The mark consists of a stylized circular design and the verbiage "assemblybio" to the right.
The applicant, Assembly Biosciences, Inc., a corporation of Delaware, having an address of
      11711 North Meridian Street, Suite 310
      Carmel, Indiana 46032
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Biopharmaceutical products, namely, pharmaceutical preparations for treating infectious diseases, gastrointestinal dysbiosis, auto-immune disorders, non-alcoholic steatohepatitis (NASH), immuno-oncology, metabolic disease, autism and oncologic conditions; Drug delivery systems in the form of capsules, tablets, softgels, powders, films and liquids that facilitate delivery of a wide range of pharmaceuticals; Drug delivery systems consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Research and development in the bio-science and biotechnology fields; Pharmaceutical, Medical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development; Conducting clinical trials for others; Drug discovery services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 5178088 and 5196452.

Miscellaneous Statement
The applicant claims ownership to pending U.S. Application Serial Number 86792363.

The applicant's current Attorney Information:
      Jessica S. Parise and Steven R. Argentieri, Stephen G. Charkoudian, Robert M. Crawford, Jr., Joel E. Lehrer, Jeffrey Rummler, Gessingga N. Storer, Bethany P. Withers, Adam M. Chud, Kevin V. Lam, Ira J. Levy, Achal Oza, Jessica Rothstein, Alexandra M. Vaccaro of Goodwin Procter LLP
      The New York Times Building
      620 Eighth Avenue
      New York, New York 10018
      United States
      212-813-8800(phone)
      212-355-3333(fax)
      TMadmin@goodwinlaw.com (authorized)
The attorney docket/reference number is ASP-611.

The applicant's current Correspondence Information:

Jessica S. Parise

Goodwin Procter LLP

The New York Times Building       620 Eighth Avenue

New York, New York 10018

212-813-8800(phone)

212-355-3333(fax)

TMadmin@goodwinlaw.com;JParise@goodwinlaw.com; SAlliRampersad@goodwinlaw.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Elizabeth H. Lacy/   Date: 04/09/2019
Signatory's Name: Elizabeth H. Lacy
Signatory's Position: General Counsel, Vice President of Legal Operations
Payment Sale Number: 88377603
Payment Accounting Date: 04/10/2019

Serial Number: 88377603
Internet Transmission Date: Tue Apr 09 14:19:40 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20190409141940551
091-88377603-620a2374c964d465948fcfe7d68
84e980845464c8ab9b47b72fca9c1e1bee5a-CC-
674-20190409112942311675